BioCentury
ARTICLE | Company News

Dainippon Sumitomo, Nippon Shinyaku deal

March 18, 2013 7:00 AM UTC

Dainippon granted Nippon exclusive rights to develop and commercialize SMP-986 in Japan for urological diseases. Dainippon will receive an undisclosed upfront payment and is eligible for milestones a...